Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tyring

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Skin Therapy Letter|December 26, 2001
Famiciclovir therapy (famvir) for herpes simplex and herpes zoster infectionsS Tyring
Skin Therapy Letter|April 12, 2001
Imiquimod applied topically: A novel immune response modifierS Tyring
The Australasian Journal of Dermatology|December 8, 1998
Immune response modification: imiquimodS Tyring
The American Journal of Medicine|May 5, 1997
Human papillomavirus and human diseaseK R Beutner, S Tyring
Viral Immunology|January 1, 1991
Purification and partial characterization of a soluble suppressor factor from papillomavirus-infected patientsV Chopra, A K Chopra, S Tyring
Anticancer Research|March 12, 1998
Failure to detect human papilloma virus in cutaneous molluscum contagiosum lesionsN Apisarnthanarax, D Payne, A Yen, et al.
The Journal of Investigative Dermatology|January 1, 1989
The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytesJ D Fine, S Tyring, W R Gammon
Immunopharmacology|December 1, 1979
Ethanol, disulfiram, and pyrazole: effects on interferon production in miceS Tyring, K Klager, A Luk, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Economic evaluation of famciclovir in reducing the duration of postherpetic neuralgiaD M Huse, S Schainbaum, A J Kirsch, et al.
International Journal of Cancer|July 15, 1982
Direct cytolysis by partially-purified preparations of immune interferonS Tyring, G R Klimpel, W R Fleischmann, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Skin Therapy Letter|December 26, 2001
Famiciclovir therapy (famvir) for herpes simplex and herpes zoster infectionsS Tyring
Skin Therapy Letter|April 12, 2001
Imiquimod applied topically: A novel immune response modifierS Tyring
The Australasian Journal of Dermatology|December 8, 1998
Immune response modification: imiquimodS Tyring
The American Journal of Medicine|May 5, 1997
Human papillomavirus and human diseaseK R Beutner, S Tyring
Viral Immunology|January 1, 1991
Purification and partial characterization of a soluble suppressor factor from papillomavirus-infected patientsV Chopra, A K Chopra, S Tyring
Anticancer Research|March 12, 1998
Failure to detect human papilloma virus in cutaneous molluscum contagiosum lesionsN Apisarnthanarax, D Payne, A Yen, et al.
The Journal of Investigative Dermatology|January 1, 1989
The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytesJ D Fine, S Tyring, W R Gammon
Immunopharmacology|December 1, 1979
Ethanol, disulfiram, and pyrazole: effects on interferon production in miceS Tyring, K Klager, A Luk, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Economic evaluation of famciclovir in reducing the duration of postherpetic neuralgiaD M Huse, S Schainbaum, A J Kirsch, et al.
International Journal of Cancer|July 15, 1982
Direct cytolysis by partially-purified preparations of immune interferonS Tyring, G R Klimpel, W R Fleischmann, et al.
Pageof 4